Alembic Pharma gets USFDA nod for generic version of Tamiflu capsules Farhat Nasim25 Jun 2019 6:24 AM GMTThe approved product, Oseltamivir Phosphate capsule is therapeutically equivalent to the reference listed drug (RLD), Tamiflu Capsules of Hoffman-La...
Alembic Pharma gets USFDA approval for Olopatadine Hydrochloride Ophthalmic Solution Farhat Nasim2 May 2019 10:34 AM GMTOlopatadine Hydrochloride Ophthalmic Solution USP, 0.2% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.New...
Alembic Pharma gets USFDA nod toTeriflunomide tablets, Tobramycin ophthalmic solution Farhat Nasim22 April 2019 6:25 AM GMTTeriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis while Tobramycin ophthalmic solution is a...
Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution Farhat Nasim15 April 2019 4:35 AM GMTBimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution Farhat Nasim17 Feb 2019 4:00 AM GMTThe company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine...
Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution Medical Dialogues Bureau10 Dec 2018 3:45 AM GMTNew Delhi: Drug firm Alembic Pharma on Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic...
Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore Ruby Khatun Khatun9 Nov 2017 4:46 AM GMTNew Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
